BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10369359)

  • 1. MR spectroscopy of bilateral thalamic gliomas.
    Estève F; Grand S; Rubin C; Hoffmann D; Pasquier B; Graveron-Demilly D; Mahdjoub R; Le Bas JF
    AJNR Am J Neuroradiol; 1999 May; 20(5):876-81. PubMed ID: 10369359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
    Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW
    Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiologic-pathologic correlation. Gliomatosis cerebri.
    Felsberg GJ; Silver SA; Brown MT; Tien RD
    AJNR Am J Neuroradiol; 1994 Oct; 15(9):1745-53. PubMed ID: 7847223
    [No Abstract]   [Full Text] [Related]  

  • 4. 3T 1H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences.
    Kim JH; Chang KH; Na DG; Song IC; Kwon BJ; Han MH; Kim K
    AJNR Am J Neuroradiol; 2006 Aug; 27(7):1412-8. PubMed ID: 16908549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral thalamic glioma: case report.
    Hirano H; Yokoyama S; Nakayama M; Nagata S; Kuratsu J
    Neuroradiology; 2000 Oct; 42(10):732-4. PubMed ID: 11110074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bilateral thalamic glioma. A clinicopathological study of 2 cases].
    Ruel JH; Broussolle E; Gonnaud PM; Jouvet A; Rousselle C; Chazot G
    Rev Neurol (Paris); 1992; 148(12):742-5. PubMed ID: 1303567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral thalamic glioma.
    Douis H; Jafri M; Sherlala K
    Arch Neurol; 2008 Dec; 65(12):1666-7. PubMed ID: 19064757
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy.
    Di Costanzo A; Scarabino T; Trojsi F; Giannatempo GM; Popolizio T; Catapano D; Bonavita S; Maggialetti N; Tosetti M; Salvolini U; d'Angelo VA; Tedeschi G
    Neuroradiology; 2006 Sep; 48(9):622-31. PubMed ID: 16752135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.
    Poptani H; Gupta RK; Roy R; Pandey R; Jain VK; Chhabra DK
    AJNR Am J Neuroradiol; 1995 Sep; 16(8):1593-603. PubMed ID: 7502961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case report on 1-year follow-up of bilateral thalamic glioma.
    Ganewatte E; Al-Zahrani Y; Purohit B; Kollias S
    Neuroradiol J; 2015 Dec; 28(6):584-6. PubMed ID: 26463006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
    Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive evaluation of cerebral glioma grade by using multivoxel 3D proton MR spectroscopy.
    Zeng Q; Liu H; Zhang K; Li C; Zhou G
    Magn Reson Imaging; 2011 Jan; 29(1):25-31. PubMed ID: 20832225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.
    Tedeschi G; Lundbom N; Raman R; Bonavita S; Duyn JH; Alger JR; Di Chiro G
    J Neurosurg; 1997 Oct; 87(4):516-24. PubMed ID: 9322842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comments and controversies: magnetic resonance spectroscopy and gliomas.
    Fan G
    Cancer Imaging; 2006 Sep; 6(1):113-5. PubMed ID: 16966066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced MR imaging techniques in the evaluation of nonenhancing gliomas: perfusion-weighted imaging compared with proton magnetic resonance spectroscopy and tumor grade.
    Sahin N; Melhem ER; Wang S; Krejza J; Poptani H; Chawla S; Verma G
    Neuroradiol J; 2013 Oct; 26(5):531-41. PubMed ID: 24199813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton MR spectroscopy of tumefactive demyelinating lesions.
    Saindane AM; Cha S; Law M; Xue X; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2002 Sep; 23(8):1378-86. PubMed ID: 12223381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral Thalamic and Right Fronto-temporo-parietal Gliomas in a 4 Years Old Child Diagnosed by Magnetic Resonance Imaging.
    Sharaf AF; Hamouda ES; Teo JG
    J Radiol Case Rep; 2016 Jan; 10(1):1-13. PubMed ID: 27200150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors.
    Bruhn H; Frahm J; Gyngell ML; Merboldt KD; Hänicke W; Sauter R; Hamburger C
    Radiology; 1989 Aug; 172(2):541-8. PubMed ID: 2748837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton MR spectroscopy in patients with neurofibromatosis type 1: evaluation of hamartomas and clinical correlation.
    Castillo M; Green C; Kwock L; Smith K; Wilson D; Schiro S; Greenwood R
    AJNR Am J Neuroradiol; 1995 Jan; 16(1):141-7. PubMed ID: 7900583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.